These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9084927)

  • 21. Exome sequencing & homozygosity mapping for identification of genetic aetiology for spastic ataxia in a consanguineous family.
    Dalal A; Bhowmik AD; Agarwal D; Phadke SR
    Indian J Med Res; 2015 Aug; 142(2):220-4. PubMed ID: 26354221
    [No Abstract]   [Full Text] [Related]  

  • 22. Recurrence risks in severe undiagnosed mental deficiency.
    Bundey S; Carter CO
    J Ment Defic Res; 1974 Jun; 18(2):115-34. PubMed ID: 4475697
    [No Abstract]   [Full Text] [Related]  

  • 23. The syndrome of retinal pigmentary degeneration, microcephaly, and severe mental retardation (Mirhosseini-Holmes-Walton syndrome): report of two patients.
    Mendez HM; Paskulin GA; Vallandro C
    Am J Med Genet; 1985 Oct; 22(2):223-8. PubMed ID: 4050854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and type of cerebral palsy in a British ethnic community: the role of consanguinity.
    Sinha G; Corry P; Subesinghe D; Wild J; Levene MI
    Dev Med Child Neurol; 1997 Apr; 39(4):259-62. PubMed ID: 9183266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incest and mental handicap.
    Jancar J; Johnston SJ
    J Ment Defic Res; 1990 Dec; 34 ( Pt 6)():483-90. PubMed ID: 2077135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation.
    Doi H; Ushiyama M; Baba T; Tani K; Shiina M; Ogata K; Miyatake S; Fukuda-Yuzawa Y; Tsuji S; Nakashima M; Tsurusaki Y; Miyake N; Saitsu H; Ikeda S; Tanaka F; Matsumoto N; Yoshida K
    Sci Rep; 2014 Nov; 4():7132. PubMed ID: 25417924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal opacity, microphthalmia, mental retardation, microcephaly and generalized muscular spasticity associated with hyperglycinemia.
    Balci S; Say B; Firat T
    Clin Genet; 1974 Jan; 5(1):36-9. PubMed ID: 4839026
    [No Abstract]   [Full Text] [Related]  

  • 28. Significance of microcephaly among children with developmental disabilities.
    Watemberg N; Silver S; Harel S; Lerman-Sagie T
    J Child Neurol; 2002 Feb; 17(2):117-22. PubMed ID: 11952071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive spasticity and developmental delay in an infant with a
    Freeman M; Fakhori N; Monteil D
    BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38871641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial DNA 8993 (NARP) mutation presenting with a heterogeneous phenotype including 'cerebral palsy'.
    Fryer A; Appleton R; Sweeney MG; Rosenbloom L; Harding AE
    Arch Dis Child; 1994 Nov; 71(5):419-22. PubMed ID: 7529982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial spastic paraplegia, mental retardation, and precocious puberty.
    Raphaelson MI; Stevens JC; Elders J; Comite F; Theodore WH
    Arch Neurol; 1983 Dec; 40(13):809-10. PubMed ID: 6639408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mutation in ALS2 associated with severe and progressive infantile onset of spastic paralysis.
    Tariq H; Mukhtar S; Naz S
    J Neurogenet; 2017; 31(1-2):26-29. PubMed ID: 28502191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sjögren-Larsson syndrome. Report of two cases in twins.
    Guilleminault CG; Harpey JP; Lafourcade J
    Neurology; 1973 Apr; 23(4):367-73. PubMed ID: 4736125
    [No Abstract]   [Full Text] [Related]  

  • 34. "Extensor toe sign" by various methods in spastic children with cerebral palsy.
    Ghosh D; Pradhan S
    J Child Neurol; 1998 May; 13(5):216-20. PubMed ID: 9620012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variant recurrence confirms the existence of a FBXO31-related spastic-dystonic cerebral palsy syndrome.
    Dzinovic I; Škorvánek M; Pavelekova P; Zhao C; Keren B; Whalen S; Bakhtiari S; Chih Jin S; Kruer MC; Jech R; Winkelmann J; Zech M
    Ann Clin Transl Neurol; 2021 Apr; 8(4):951-955. PubMed ID: 33675180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying genes responsible for intellectual disability in consanguineous families.
    Iqbal Z; van Bokhoven H
    Hum Hered; 2014; 77(1-4):150-60. PubMed ID: 25060278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic factors in athetoid cerebral palsy.
    Amor DJ; Craig JE; Delatycki MB; Reddihough D
    J Child Neurol; 2001 Nov; 16(11):793-7. PubMed ID: 11732763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel GBA2 gene missense mutation in spastic ataxia.
    Votsi C; Zamba-Papanicolaou E; Middleton LT; Pantzaris M; Christodoulou K
    Ann Hum Genet; 2014 Jan; 78(1):13-22. PubMed ID: 24252062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and videofluoroscopic evaluation of swallowing in patients with spastic tetraparetic cerebral palsy and athetosic cerebral palsy].
    Silva AB; Piovesana AM; Barcelos IH; Capellini SA
    Rev Neurol; 2006 Apr 16-30; 42(8):462-5. PubMed ID: 16625507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.